Louis Ferland

ResearchDX - Louis Ferland

Louis Ferland, PhD, PMP
VP, Regulatory Affairs

Dr. Ferland received his PhD in Experimental Medicine from McGill University in Montreal, Canada, and followed his doctorate work with two post-doctoral fellowships at the Salk Institute in La Jolla, California, USA, and at the Institut Pasteur in Paris, France.

Dr. Ferland then initiated an academic research career at the Burn Unit of the Hôtel-Dieu de Montréal Hospital Research Center (Université de Montréal), but eventually transferred his energy into the biotech industry arena. He helped in the buildup and growth of several start-up companies (he was company employee #1, twice) before joining the ranks of 454 Life Sciences, then itself a start-up. At 454, Dr. Ferland was instrumental in the development and release to market of the first-ever “next-generation sequencing” system, and in the company’s successful acquisition by Roche Diagnostics, in 2007.

Dr. Ferland’s areas of expertise include molecular biology/genomics, endocrinology and metabolism, cancer, molecular diagnostics, and medical devices. He is also an accomplished technical/medical writer who has solid experience in the areas of quality and safety and with the preparation and management of regulatory submissions for medical devices. Dr. Ferland is also a certified Project Management Professional (PMP) from the Project Management Institute.